Orbitopatía tiroidea: protocolo de manejo basado en revisión de la evidencia

Orbitopatía tiroidea: protocolo de manejo basado en revisión de la evidencia

La orbitopatía tiroidea es una patología potencialmente grave que amenaza la visión. Es la manifestación extratiroidea más frecuente de la enfermedad de Graves y, aunque la prevalencia no está evaluada en Colombia, puede producir pérdida de la visión, con consecuencias catastróficas. Teniendo en cu...

Full description

Bibliographic Details
Main Authors:	C. Gómez, A. Imitola, L. B. Taboada, D. C. Henao, L. F. Marín, J. Camargo, L. Kattath, C. Fonseca, C. Colón, P. Ascnher
Format:	Article
Language:	English
Published:	Asociación Colombiana de Endocrinología 2019-10-01
Series:	Revista Colombiana de Endocrinología, Diabetes y Metabolismo
Subjects:	oftalmopatía de Graves enfermedad de Graves glucocorticoides rituximab radioterapia
Online Access:	https://revistaendocrino.org/index.php/rcedm/article/view/535

Similar Items

Efectividad y seguridad de tocilizumab en 2 casos de orbitopatía tiroidea grave refractaria a corticosteroides. Hospital San José, Bogotá
by: A. Sierra Osorio, et al.
Published: (2021-06-01)

Patogenia y tratamiento médico de la orbitopatía de graves
by: V. Soledad Hidalgo, Dra.
Published: (2010-11-01)

Orbitopatía tiroidea
by: Alfredo Jácome Roca
Published: (2020-04-01)

Adulto eutiroideo con oftalmopatía de Graves unilateral: reporte de caso y revisión de tema
by: Pablo Coste Murillo, et al.
Published: (2016-12-01)

Thyroid orbitopathy. A pathophysiologic enigma and a therapeutic dilemma
by: Tamara de las Mercedes Galbán Lueje, et al.
Published: (2014-12-01)

Enfermedad de Graves y orbitopatía tiroidea en el embarazo
by: Oscar David Lucero Pantoja, et al.
Published: (2023-06-01)

Patrones de práctica clínica en la enfermedad de Graves en Colombia
by: Diego Armando Perdomo-Par, et al.
Published: (2021-12-01)

Prolapso de gordura orbitária e oftalmopatia de Graves Orbital fat prolapse and Graves' ophthalmopathy
by: Kim-Ir-Sen Santos Teixeira, et al.
Published: (2009-04-01)

Oftalmopatia Tiroideia Severa e Tiroidite de Hashimoto, em Doente Eutiroideu
by: Raquel Espírito Santo, et al.
Published: (2016-09-01)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
by: Tülay Şimşek, et al.
Published: (2017-01-01)

Rituximab in the treatment of Graves’ orbitopathy: latest updates and perspectives
by: Jakub Supronik, et al.
Published: (2022-11-01)

Increased heart rhythm in response to high-dose intravenous methylprednisolone pulse therapy of moderate-to-severe Graves’ orbitopathy.
by: Klaudia Gutowska, et al.
Published: (2023-02-01)

Manifestações oculares de doenças sistêmicas: uveítes, Oftalmopatia de Graves e Síndrome de Sjögren
by: João M. Furtado, et al.
Published: (2022-09-01)

Rituximab therapy in steroid-resistant severe hypothyroid Grave′s ophthalmopathy
by: Aditi Pandit, et al.
Published: (2013-01-01)

Use of Rituximab After Orbital Decompression Surgery in Two Grave’s Ophthalmopathy Patients Progressing to Optic Neuropathy
by: Benping Zhang, et al.
Published: (2020-10-01)

Precision Medicine in Graves’ Disease and Ophthalmopathy
by: Giusy Elia, et al.
Published: (2021-10-01)

Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves’ Orbitopathy
by: Irene Campi, et al.
Published: (2022-01-01)

Espessamento do tendão muscular na oftalmopatia de Graves
by: Elvira Barbosa Abreu
Published: (2011-12-01)

Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy
by: Jun Jia, et al.
Published: (2022-04-01)

Intravenous glucocorticoids therapy in the treatment of Graves’ ophthalmopathy: a systematic review and Meta-analysis
by: Li-Quan Zhao, et al.
Published: (2019-07-01)

Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01)

Frecuencia y características clínicas de la orbitopatía asociada al tiroides en pacientes hipertiroideos de reciente diagnóstico
by: Marelis Yanes Quesada, et al.

Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate
by: Katarzyna Pelewicz, et al.
Published: (2020-10-01)

Descompresión orbitaria endoscópica transnasal en orbitopatía por enfermedad de Graves
by: Martín Alonso Pinzón Navarro, et al.
Published: (2017-03-01)

Hipertiroidismo: Enfermedad de Grave´s
by: Hernando Vargas Uricoechea
Published: (2005-01-01)

Tratamiento quirúrgico del estrabismo en la enfermedad de graves
by: Dr. C. Iván Villaseca
Published: (2010-11-01)

What kind of therapeutic solutions for Graves’ disease does modern medicine propose? - a review of the literature
by: Natalia Woś, et al.
Published: (2023-05-01)

Dysthyroid Optic Neuropathy: Treatment with Additional Intravenous Methylprednisolone Pulses after the Basic Schedule Is Associated with Stabilization or Further Improvement of Clinical Outcome
by: Maryla Pelewicz, et al.
Published: (2022-04-01)

Current Knowledge on Graves’ Orbitopathy
by: Katarzyna Gontarz-Nowak, et al.
Published: (2020-12-01)

Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Joanna Rymuza, et al.
Published: (2022-08-01)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
by: Poupak Fallahi, et al.
Published: (2021-04-01)

Apresentação atípica da oftalmopatia de Graves
by: Flávia Marques Rodrigues, et al.
Published: (2015-08-01)

El uso de glucocorticoides en neumonía grave adquirida de la comunidad
by: Alegre G, et al.
Published: (2020-07-01)

MODERN APPROACHES TO THE THERAPY OF ENDOCRINE OPHTHALMOPATHY
by: Nikonova L. V., et al.
Published: (2019-03-01)

Importancia de la Medición de Triiodotironina en Suero como Prueba de Evaluación Tiroidea
by: Jorge E. Gaitán, et al.
Published: (2018-01-01)

Efficacy and Safety of intravenous monoclonal antibodies in patients with moderate-to-severe active Graves’ophthalmopathy: a systematic review and meta-analysis
by: Yu Hu, et al.
Published: (2023-05-01)

Transforming growth factor β1 (TGF-β1) in patients with endocrine ophthalmopathy and Graves’ disease: A predictor of treatment efficiency
by: N. Yu. Sviridenko, et al.
Published: (2022-11-01)

Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
by: Tsirouki T, et al.
Published: (2016-11-01)

Graves’ ophtalmopathy
by: Satvinder Bakshi
Published: (2022-02-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)